Screener
Dianthus Therapeutics DNTH Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Dianthus Therapeutics’s 10-Q, filed November 5, 2025. Open the filing →
- Filed
- Nov 5, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-266920
FAQ
- What is Dianthus Therapeutics's return on invested capital?
- Dianthus Therapeutics (DNTH) reported return on invested capital of -35.2% in Q3 2025.
- How has Dianthus Therapeutics's return on invested capital changed year-over-year?
- Dianthus Therapeutics's return on invested capital increased by 30.6% year-over-year, from -50.8% to -35.2%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Dianthus Therapeutics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude